Owning the code of life : human gene patents in America

Thesis: S.M., Massachusetts Institute of Technology, Department of Comparative Media Studies, 2015.

Bibliographic Details
Main Author: Schwartz, Sarah L. (Sarah Leah)
Other Authors: Thomas Levenson.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2016
Subjects:
Online Access:http://hdl.handle.net/1721.1/101364
_version_ 1811091515226718208
author Schwartz, Sarah L. (Sarah Leah)
author2 Thomas Levenson.
author_facet Thomas Levenson.
Schwartz, Sarah L. (Sarah Leah)
author_sort Schwartz, Sarah L. (Sarah Leah)
collection MIT
description Thesis: S.M., Massachusetts Institute of Technology, Department of Comparative Media Studies, 2015.
first_indexed 2024-09-23T15:03:36Z
format Thesis
id mit-1721.1/101364
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T15:03:36Z
publishDate 2016
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/1013642022-08-09T20:17:26Z Owning the code of life : human gene patents in America Human gene patents in America Schwartz, Sarah L. (Sarah Leah) Thomas Levenson. Massachusetts Institute of Technology. Department of Comparative Media Studies. Massachusetts Institute of Technology. Graduate Program in Science Writing Comparative Media Studies. Thesis: S.M., Massachusetts Institute of Technology, Department of Comparative Media Studies, 2015. Cataloged from PDF version of thesis. Includes bibliographical references (pages 49-54). In 2013, the United States Supreme Court heard the case of Association of Molecular Pathology v. Myriad Genetics. The case asked one question: are human genes patentable? Gene patents became commonplace during the biotechnology revolution of the 1980s, but generated a complex web of moral, legal, and biological questions. While some viewed gene patents as necessary in promoting and sustaining innovation, others felt that owning the code of life was morally and legally misguided. This tension played a central role in the early years of the Human Genome Project, and continued as people experienced the challenging consequences of assigning property rights to our shared biology. Several patients with genetic diseases were forced to navigate limited or expensive testing because of a company's genetic monopoly. Some scientists worried that their research might infringe a patent. When the Supreme Court decided the Myriad trial, ruling that unaltered human genes were not patent-eligible, their decision marked a surprising and historic shift in the relationship between patent law and fundamental biology-but questions and uncertainty about a future without gene patents remain. by Sarah L. Schwartz. S.M. 2016-02-29T15:02:55Z 2016-02-29T15:02:55Z 2015 2015 Thesis http://hdl.handle.net/1721.1/101364 939625925 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 54 pages application/pdf Massachusetts Institute of Technology
spellingShingle Comparative Media Studies.
Schwartz, Sarah L. (Sarah Leah)
Owning the code of life : human gene patents in America
title Owning the code of life : human gene patents in America
title_full Owning the code of life : human gene patents in America
title_fullStr Owning the code of life : human gene patents in America
title_full_unstemmed Owning the code of life : human gene patents in America
title_short Owning the code of life : human gene patents in America
title_sort owning the code of life human gene patents in america
topic Comparative Media Studies.
url http://hdl.handle.net/1721.1/101364
work_keys_str_mv AT schwartzsarahlsarahleah owningthecodeoflifehumangenepatentsinamerica
AT schwartzsarahlsarahleah humangenepatentsinamerica